Name: Clinical Research Partners
Price range: $$

The BALANCE Study is testing an oral study drug called camlipixant to see if it helps adults with 2 forms of irritable bowel syndrome (IBS-D or IBS-M). IBS-D involves mostly diarrhea, while IBS-M includes both diarrhea and constipation.

Get Your Patient Form Download Brochure

804-477-3045

Get Your Patient Form

Summary

The study drug is being tested to see if it can reduce the activation of nerves in the gut that trigger abdominal pain, stool irregularity, and other IBS symptoms. During the study, camlipixant or placebo is taken as a tablet twice each day, and it is hoped that camlipixant will help improve the quality of life of people affected by IBS-D and IBS-M.

Age

18 to 80 years old

Qualifications

You may be able to join if you:

Are 18 to 80 years old
Have a diagnosis of IBS-D or IBS-M
Are troubled by abdominal pain and abnormal stools
Are willing to hold off certain IBS medications for the study
Can use an electronic diary to track your symptoms daily

If you qualify, you will receive:

The investigational oral study drug, which may reduce IBS symptoms, or a placebo, which looks like the study drug but has no active ingredients.
Close study-related medical care and follow-up throughout the study.
Reimbursement for reasonable study-related expenses, and a stipend for attending study visits and completion of study diary.